Kulke MH - Search Results

1

Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer.

Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, Kawasaki T, Kinsella K, Michelini AL, Enzinger PC, Kulke MH, Ryan DP, Loda M, Fuchs CS. Ogino S, et al. Among authors: kulke mh. Clin Cancer Res. 2005 Sep 15;11(18):6650-6. doi: 10.1158/1078-0432.CCR-05-0738. Clin Cancer Res. 2005. PMID: 16166444 Clinical Trial.

2

Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.

Kulke MH, Odze RD, Thakore KS, Thomas G, Wang H, Loda M, Eng C. Kulke MH, et al. Br J Cancer. 2001 Mar 23;84(6):748-53. doi: 10.1054/bjoc.2000.1660. Br J Cancer. 2001. PMID: 11259087 Free PMC article.

3

Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma.

Kulke MH, Thakore KS, Thomas G, Wang H, Loda M, Eng C, Odze RD. Kulke MH, et al. Cancer. 2001 Apr 15;91(8):1451-7. doi: 10.1002/1097-0142(20010415)91:8<1451::aid-cncr1152>3.0.co;2-z. Cancer. 2001. PMID: 11301392

4

Malignant transformation of the esophageal mucosa is enhanced in p27 knockout mice.

Ellis FH Jr, Xu X, Kulke MH, LoCicero J 3rd, Loda M. Ellis FH Jr, et al. Among authors: kulke mh. J Thorac Cardiovasc Surg. 2001 Oct;122(4):809-14. doi: 10.1067/mtc.2001.116471. J Thorac Cardiovasc Surg. 2001. PMID: 11581618 Free article.

5

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.

Ryan DP, Kulke MH, Fuchs CS, Grossbard ML, Grossman SR, Morgan JA, Earle CC, Shivdasani R, Kim H, Mayer RJ, Clark JW. Ryan DP, et al. Among authors: kulke mh. Cancer. 2002 Jan 1;94(1):97-103. doi: 10.1002/cncr.10202. Cancer. 2002. PMID: 11815964 Free article. Clinical Trial.

6

A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer.

Kulke MH, Demetri GD, Sharpless NE, Ryan DP, Shivdasani R, Clark JS, Spiegelman BM, Kim H, Mayer RJ, Fuchs CS. Kulke MH, et al. Cancer J. 2002 Sep-Oct;8(5):395-9. doi: 10.1097/00130404-200209000-00010. Cancer J. 2002. PMID: 12416897 Clinical Trial.

7

Recent developments in the pharmacological treatment of advanced pancreatic cancer.

Kulke MH. Kulke MH. Expert Opin Investig Drugs. 2003 Jun;12(6):983-92. doi: 10.1517/13543784.12.6.983. Expert Opin Investig Drugs. 2003. PMID: 12783602 Review.

8

A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.

Ryan DP, Clark JW, Kulke MH, Fuchs CS, Earle CC, Enzinger PC, Stuart K, Catarius KJ, Winkelmann J, Mayer RJ. Ryan DP, et al. Among authors: kulke mh. Cancer Invest. 2003;21(4):505-11. doi: 10.1081/cnv-120022359. Cancer Invest. 2003. PMID: 14533439 Clinical Trial.

9

Advanced pancreatic cancer: is there a role for combination therapy?

Kulke MH. Kulke MH. Expert Rev Anticancer Ther. 2003 Oct;3(5):729-39. doi: 10.1586/14737140.3.5.729. Expert Rev Anticancer Ther. 2003. PMID: 14599095 Review.

10

A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

Kulke MH, Kim H, Clark JW, Enzinger PC, Lynch TJ, Morgan JA, Vincitore M, Michelini A, Fuchs CS. Kulke MH, et al. Cancer. 2004 Sep 1;101(5):934-9. doi: 10.1002/cncr.20466. Cancer. 2004. PMID: 15329900 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters